Intravitreal ranibizumab for patients with neovascular age-related macular degeneration with good baseline visual acuity
Not Applicable
- Conditions
- neovascular age-related macular degeneration
- Registration Number
- JPRN-UMIN000015073
- Lead Sponsor
- Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) the patients who were undergone previous treatment such aslaser photocoagulation, intravitreal triamcinolone, intravitreal anti VEGF or photodynamic therapy. 2) the patients who were undergone vitrectomy 3) the patients who has allergy for fluorescein and indocyanine green
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method best-corrected visual acuities
- Secondary Outcome Measures
Name Time Method central retinal thickness